Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1B | P00325 | 4/20 | 1.00 |
| ▸ | ADH1C | P00326 | 4/20 | 1.00 |
| ▸ | ADH1A | P07327 | 4/20 | 1.00 |
| ▸ | ADH7 | P40394 | 3/20 | 1.00 |
| ▸ | ADH4 | P08319 | 2/20 | 1.00 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.38 |
| ▸ | GAPDH | P04406 | 1/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.38 |
| ▸ | FDPS | P14324 | 3/20 | 0.38 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10576995 | 1.00 | ADH1B (1.00) | ADH1BADH1CADH1AADH7ADH4 | |
| SCHEMBL11076771 | 1.00 | ADH1B (1.00) | ADH1BADH1CADH1AADH7ADH4 | |
| SCHEMBL11331034 | 1.00 | ADH1B (1.00) | ADH1BADH1CADH1AADH7ADH4 | |
| SCHEMBL277123 | 1.00 | ADH1B (1.00) | ADH1BADH1CADH1AADH7ADH4 | |
| SCHEMBL9797220 | 1.00 | ADH1B (1.00) | ADH1BADH1CADH1AADH7ADH4 | |
| SCHEMBL11078050 | 1.00 | ADH1B (1.00) | ADH1BADH1CADH1AADH7ADH4 | |
| SCHEMBL2112386 | 1.00 | ADH1B (1.00) | ADH1BADH1CADH1AADH7ADH4 | |
| SCHEMBL11077984 | 1.00 | ADH1B (1.00) | ADH1BADH1CADH1AADH7ADH4 | |
| SCHEMBL20539967 | 1.00 | ADH1B (1.00) | ADH1BADH1CADH1AADH7ADH4 | |
| SCHEMBL11276705 | 1.00 | ADH1B (1.00) | ADH1BADH1CADH1AADH7ADH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0230224-B1 | PROCESS FOR THE PREPARATION OF ALCOXYCARBONYL ISOCYANATES | BAYER AG (DE) | 1991-07-17 | — | — | EP | claimed |
| EP-1598331-B1 | Process for the preparation of phthalic acid dichloride | SALTIGO GMBH (DE) | 2009-07-15 | — | — | EP | disclosed |
| US-7154003-B2 | Process for preparing phthaloyl chloride | LANXESS DEUTSCHLAND GMBH (DE) | 2006-12-26 | — | — | US | disclosed |
| US-20050277788-A1 | Process for preparing phthaloyl chloride | LANXESS DEUTSCHLAND GMBH (DE) | 2005-12-15 | — | — | US | disclosed |
| EP-1598331-A1 | Process for the preparation of phthalic acid dichloride | Lanxess Deutschland GmbH (DE) | 2005-11-23 | — | — | EP | disclosed |
| US-5977029-A | HERBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1999-11-02 | — | — | US | disclosed |
| US-5393729-A | Pesticides, fungicides, herbicides | BAYER AKTIENGESELLSCHAFT (DE) | 1995-02-28 | — | — | US | disclosed |
| US-4880576-A | HALOGENATION OF ACIDS, FORMAMIDE CATALYSTS | BAYER AKTIENGESELLSCHAFT (DE) | 1989-11-14 | — | — | US | disclosed |
| EP-0050790-B1 | PREPARATION OF ALPHA-CHLORINATED NITROGEN HETEROCYCLES | BAYER AG (DE) | 1984-12-19 | — | — | EP | disclosed |
| EP-0050779-B1 | N-ALKYLATED FORMAMIDES, PROCESS FOR THEIR PREPARATION AND THEIR USE | BAYER AG (DE) | 1984-05-16 | — | — | EP | disclosed |
| EP-0050779-A1 | N-alkylated formamides, process for their preparation and their use | BAYER AG (DE) | 1982-05-05 | — | — | EP | disclosed |
| EP-0050790-A1 | Preparation of alpha-chlorinated nitrogen heterocycles | BAYER AG (DE) | 1982-05-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050277788-A1 | Process for preparing phthaloyl chloride | PHYKPL, PFAS, PGLS | ADH1B 2807/4885ADH1C 2554/4885ADH1A 3390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.